SCHEMBL5368754

SCHEMBL5368754

Nc1ccc(SCc2ccc(F)cc2Cl)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.56
CRHBP P24387 1/20 0.56
CRHR2 Q13324 1/20 0.56
HSD17B10 Q99714 1/20 0.56
RAB9A P51151 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
NPC1 O15118 2/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2C19 P33261 2/20 0.49
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 1/20 0.47
KMT2A Q03164 1/20 0.47
KDM4E B2RXH2 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.41
TP53 P04637 3/20 0.40
P2RX7 Q99572 2/20 0.38
MAPT P10636 1/20 0.38
PDE7A Q13946 1/20 0.38
IDO1 P14902 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5321349 0.78 ALOX15 (0.53) ALOX15CRHBPCRHR2HSD17B10RAB9A
SCHEMBL6237872 0.77 CYP1A2 (0.43) ALOX15CRHBPCRHR2HSD17B10RAB9A
SCHEMBL21186285 0.75 CYP3A4 (0.45) ALOX15CRHBPCRHR2HSD17B10MEN1
SCHEMBL13256328 0.72 IDO1 (0.71) ALOX15CRHBPCRHR2HSD17B10SMN1; SMN2
SCHEMBL11095257 0.72 CYP1A2 (0.64) RAB9ASMN1; SMN2NPC1CYP1A2CYP2C19
SCHEMBL5372112 0.72 ALDH1A1 (0.67) RAB9ANPC1MEN1ALDH1A1KMT2A
SCHEMBL1632417 0.71 PSEN1 (0.49) RAB9ASMN1; SMN2NPC1MEN1ALDH1A1
SCHEMBL5921916 0.71 RAB9A (0.56) ALOX15HSD17B10RAB9ASMN1; SMN2MEN1
SCHEMBL28923643 0.71 SMN1; SMN2 (0.76) ALOX15CRHBPCRHR2HSD17B10RAB9A
SCHEMBL5376607 0.70 NPC1 (0.55) RAB9ASMN1; SMN2NPC1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
CN-1930121-A Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER PROD INC (US) 2007-03-14 CN disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD ALOX15 1494/4885CRHBP 2286/4885CRHR2 3847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.